San Francisco Bay Area Faces Ongoing Market Challenges
While several U.S. life science markets have begun to stabilize or show early signs of recovery, San Francisco/San Jose remains in a period of adjustment as new supply continues to …
bay area life science demand
Newer Life Science Properties Driving Occupancy Losses Across the Sector
The US Life Science or Biotech real estate sector has seen tremendous growth during the past 3 years. Overall, since 2Q22, the US Life Science sector has grown by 17% to 401 million square feet (MSF) in 2Q25.
New Deliveries, Older Properties Most Impacted by Oversupply
Last year Life Science inventory in the top 3 clusters, Boston, San Francisco & San Diego, grew by over 10%. With this incredible growth, combined with softer space demand, many …
Life Science Cluster Performance Varies Widely
Revista tracks life science properties across the entire U.S. and virtually every area has felt an impact from reduced space demand combined with overbuilding. That being said, not every life …
4th Quarter Life Science Real Estate Update – Slides and Webinar
RevistaLab.com recently held its 4th quarter life science real estate update. Revista principals, Hilda Martin and Mike Hargrave presented RevistaLab data on construction trends, transactions, occupancies, supply/demand fundamentals across the …
Supply Growth Pressuring Occupancy in the Boston CBSA
It is no secret that inventory has been increasing lately in many life science real estate markets. Developers have been responding to increasing demand for new space during the past years, especially coming out of the COVID-19 pandemic era
San Francisco Shows Resilience in 2023
Many metros are struggling this year to absorb new Life Science inventory as funding has significantly scaled back and companies become more cautious on space needs. After struggling to absorb …